Bought
~$560K15K sh @ $37.32
Traded Sep 30 · filed 1 day later
The CFO of Xenon Pharmaceuticals paid $560K out of pocket for Xenon Pharmaceuticals shares. 1 other person at Xenon Pharmaceuticals bought some too, in the same month.
Loading…
Traded Sep 30, 2026 · Filed Oct 1, 2026
The CEO of Xenon Pharmaceuticals paid $1.12M out of pocket for Xenon Pharmaceuticals shares. 1 other person at Xenon Pharmaceuticals bought some too, in the same month. The Xenon Pharmaceuticals shares held grew by 151%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$1,121,400
Shares × reported transaction price
$1M+
+150.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
55 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Sep 30 · filed 1 day later
The CFO of Xenon Pharmaceuticals paid $560K out of pocket for Xenon Pharmaceuticals shares. 1 other person at Xenon Pharmaceuticals bought some too, in the same month.